We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFY icon
3126
Infosys
INFY
$51B
$44K ﹤0.01%
2,074
-34,237
-94% -$654K
MGY icon
3127
Magnolia Oil & Gas
MGY
$6.17B
$44K ﹤0.01%
2,789
-11,915
-81% -$153K
MX icon
3128
Magnachip Semiconductor
MX
$142M
$44K ﹤0.01%
+1,864
New +$45.7K
NEWP
3129
New Pacific Metals
NEWP
$1.16B
$44K ﹤0.01%
+9,310
New +$49.1K
TBPH icon
3130
Theravance Biopharma
TBPH
$878M
$44K ﹤0.01%
3,024
+650
+27% +$12.2K
TNC icon
3131
Tennant Co
TNC
$1.17B
$44K ﹤0.01%
549
-1,505
-73% -$123K
TSQ icon
3132
Townsquare Media
TSQ
$108M
$44K ﹤0.01%
+3,490
New +$41.5K
UAN icon
3133
CVR Partners
UAN
$1.25B
$44K ﹤0.01%
+705
New +$39.5K
PVLA
3134
Palvella Therapeutics
PVLA
$2.22B
$44K ﹤0.01%
144
+5
+4% +$1.1K
LGTY
3135
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$44K ﹤0.01%
2,012
-678
-25% -$14.3K
MCBC
3136
DELISTED
Macatawa Bank Corp
MCBC
$44K ﹤0.01%
5,073
+3,573
+238% +$34.1K
TCRR
3137
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$44K ﹤0.01%
2,692
+425
+19% +$8.59K
BIOR
3138
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$44K ﹤0.01%
50
+16
+47% +$12.2K
CMO
3139
DELISTED
Capstead Mortgage Corp.
CMO
$44K ﹤0.01%
7,273
-35,534
-83% -$229K
ANNX icon
3140
Annexon
ANNX
$854M
$43K ﹤0.01%
1,922
+551
+40% +$12.2K
DORM icon
3141
Dorman Products
DORM
$3.99B
$43K ﹤0.01%
413
-3,903
-90% -$400K
FLNT
3142
Fluent
FLNT
$120M
$43K ﹤0.01%
2,455
+1,558
+174% +$30.7K
FUNC icon
3143
First United
FUNC
$290M
$43K ﹤0.01%
2,472
+1,509
+157% +$27.2K
HSBC icon
3144
HSBC
HSBC
$355B
$43K ﹤0.01%
1,495
-470
-24% -$14.4K
IMVT icon
3145
Immunovant
IMVT
$8.08B
$43K ﹤0.01%
4,087
-1,659
-29% -$23.2K
KROS icon
3146
Keros Therapeutics
KROS
$210M
$43K ﹤0.01%
1,010
+448
+80% +$24.3K
MCRI icon
3147
Monarch Casino & Resort
MCRI
$2.24B
$43K ﹤0.01%
654
-1,543
-70% -$107K
NFBK
3148
DELISTED
Northfield Bancorp
NFBK
$43K ﹤0.01%
2,642
-942
-26% -$15.5K
PDFS icon
3149
PDF Solutions
PDFS
$2.12B
$43K ﹤0.01%
2,373
-2,608
-52% -$46.7K
PNRG icon
3150
PrimeEnergy Resources
PNRG
$320M
$43K ﹤0.01%
916
-297
-24% -$13.5K
124 125
126
127 128

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.